View Section: Cash Flow Statement
RX
Recursion Pharmaceuticals IncNASDAQ RXRX Stock Report
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
1.859
Small
Exchange
XNAS - Nasdaq
RX
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
1.859
Exchange
XNAS - Nasdaq
RX
Ex-dividend date
Amount
Share price
Yield
This ticker has no dividend history